Page last updated: 2024-10-23

azathioprine and ARSA Deficiency

azathioprine has been researched along with ARSA Deficiency in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Research Excerpts

ExcerptRelevanceReference
"A 4-year-old child with metachromatic leukodystrophy was initially diagnosed with chronic immune demyelinating polyneuropathy and treated with immunosuppressive therapy."1.29Neuropathy of metachromatic leukodystrophy: improvement with immunomodulation. ( Carroll, SL; Lopate, G; Nevo, Y; Pestronk, A, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nevo, Y1
Pestronk, A1
Lopate, G1
Carroll, SL1

Other Studies

1 other study available for azathioprine and ARSA Deficiency

ArticleYear
Neuropathy of metachromatic leukodystrophy: improvement with immunomodulation.
    Pediatric neurology, 1996, Volume: 15, Issue:3

    Topics: Azathioprine; Child, Preschool; Cyclosporine; Female; Humans; Immunization, Passive; Immunosuppressi

1996